You are here

  • Home
  • Archive
  • Volume 14, Issue 6
  • Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults

Citation Tools

Article menu
Neurology
Protocol
Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Koychev I, Adler AI, Edison P, et al
Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults
BMJ Open 2024;14:e081401. doi: 10.1136/bmjopen-2023-081401